Last reviewed · How we verify
A Randomized, Double-blind, Placebo-controlled, Multi-center Parallel Group Phase IV Study to Evaluate the Efficacy and Safety of Diclofenac 1.16% Gel in Subjects With Acute Neck Pain
The purpose of this study is to evaluate the efficacy and safety of diclofenac 1.16% gel compared with placebo applied four times a day in subjects with acute neck pain.
Details
| Lead sponsor | Novartis |
|---|---|
| Phase | Phase 4 |
| Status | COMPLETED |
| Enrolment | 72 |
| Start date | 2011-04 |
| Completion | 2011-07 |
Conditions
- Neck Pain
Interventions
- Diclofenac diethylamine 1.16% gel
- Placebo gel
Primary outcomes
- Pain on Movement — 48 h
Pain on movement on a 100 mm visual analog scale. Minimum score =0 mm "no pain". Maximum score =100 mm "extreme pain".
Countries
Germany